These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ketolides: the future of the macrolides? Nilius AM; Ma Z Curr Opin Pharmacol; 2002 Oct; 2(5):493-500. PubMed ID: 12324249 [TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae. Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of novel C12 vinyl ketolides. Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588 [TBL] [Abstract][Full Text] [Related]
17. Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro. Labro MT; Abdelghaffar H; Babin-Chevaye C Antimicrob Agents Chemother; 2004 Apr; 48(4):1096-104. PubMed ID: 15047507 [TBL] [Abstract][Full Text] [Related]